Description
This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 4
Primary Industries
- Drugs
- Medical
- Biotechnology
- Personal Care Products
- Diagnostic
- Pharmaceuticals
- Veterinary
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 28632
License Grant
Technology License Grant. Licensor hereby grants to Licensee a limited, non-assignable, non-transferable, nonÂsublicensable, royalty-bearing license to use and practice the Technology, solely for the provision of the Tissue Processing and solely within the Territory, and strictly for no other purposes. For the Term of this Agreement, said License shall be an exclusive License as to the Territory; however, Licensor retains the right to grant such other licenses to Third Parties in geographic areas outside of the Territory.
Licensor is willing to grant such License, upon the terms and conditions hereinafter set forth, and the first right of refusal for exclusive License in the areas of Ft Myers and Tampa, Florida.
License Property
Licensor is the owner of the Patent, Trademarks and Technology.
Technology shall mean the combination of technology, know-how and other intellectual property defined in the Patent and in other materials, provided by Licensor and affiliates of Licensor and which is required for the Tissue Processing.
Tissue Processing shall mean the separation of Adipose Stromal Vascular Fraction from fat tissue of Licensee's patients utilizing the Technology.
61/427,221; Ultrasonic Cavitation of Adipose Tissue to produce stromal vascular fraction; and 61/384,183; Stromal Vascular Fraction (SVF) or adipose derived regenerative cells (ADRC) used for intradermal injections for wrinkles, skin tightening, hair growth and mucous gum regeneration.
Trademarks
[IntelliCell]
[IntelliCell BioScience]
Stromal vascular fraction (SVF) of adipose tissue is a rich source of preadipocytes, mesenchymal stem cells (MSC), endothelial progenitor cell, T cells, B cells, mast cells as well as adipose tissue macrophages.
Field of Use
Licensee desires, for the Term of this Agreement, to obtain a nonexclusive License, but exclusive within a defined geographic area as set forth herein, for the use and practice of the Patent, Technology and Trademarks.
The Non-Exclusive rights granted apply to the use and practice the Technology, solely for the provision of the Tissue Processing and solely within the Territory, and strictly for no other purposes.
Use of Trademark Licensee shall use and display the Trademarks only in such forms as specifically approved in writing in advance by Licensor, including without limitation, use of the Trademarks on advertising, promotional or publicity materials, displays, stationary or business cards and shall not use the Trademarks on any such items unless so approved. Licensee shall not use any of the Trademarks in its corporate name or file any d/b/a incorporating the Trademarks, except as approved by Licensor. Licensor approves of the d/b/a of IntelliCell BioSciences of Palm Beach for use by Licensee.
IPSCIO Record ID: 27530
License Grant
Licensor grants to Licensee an exclusive, non-assignable, non-transferable, license to utilize and commercially exploit the licensed Technology, solely for the provision of Tissue Processing and solely within the Territory, and strictly for no other purposes; the right to grant sublicenses and a right of first refusal to acquire a license in respect of any other applications of the Patents and Technology in the Territory. Licensee agrees that all efforts to exploit the licensed Technology shall be made under and using the name “IntelliCell Thailand†or such other similar name as may be approved by Licensor.
Subject to the terms and conditions of this Agreement, Licensor hereby grants to Licensee an exclusive, non-assignable, non-transferable, royalty-bearing license to use the Trademarks, solely in connection with the Tissue Processing and solely within the Territory.
License Property
Licensor is the owner or otherwise has developed and/or controls certain pending Patents and Technology to be marketed under protected trademarks owned the Licensor.
“Tissue Processing†shall mean the separation of Adipose Stromal Vascular Fraction from fat tissue utilizing the Technology.
[Patent Patent Application] Ultrasonic Cavitation for the separation of Stromal Vascular Fraction from Adipose Tissue
Field of Use
Licensee desires to obtain an exclusive License from the Licensor to utilize the Patents and Technology so that Licensee can provide Tissue Processing services for Physicians in the territory and/or grant further sub-Licenses of the Licensed Technology in the territory.
IPSCIO Record ID: 27634
License Grant
Licensee hereby grants to Licensor a non-exclusive (except for the Pensacola Florida Area and surrounding radius of 150 miles) non-assignable, non-transferable, non-sub licensable license during the Term hereof to market the use of and practice the Technology at Licensor’s premises, solely for the provision of Tissue Processing and other Services, and strictly for no other purposes. This licensing transaction is primarily the Licensee granting to the Licensor the rights described above but within the license is an exception where the Licensee pays the Licensor a royalty on sales if it opens up a laboratory in the area designated (Pensacola Florida area).
License Property
Licensee is the owner or otherwise has developed and/or controls certain Patents and Technology utilized for the purpose of providing tissue processing services that result in the separation of Adipose Stromal Vascular Fraction from fat tissue; and WHEREAS, Licensor desires to license from Licensee certain of the Patents and Technology to establish a Tissue Processing facility on Licensor’s premises for the purpose of utilizing the Technology and providing Tissue Processing services for Licensor’s own patients.
IPSCIO Record ID: 7061
License Grant
Licensor hereby grants to Licensee an exclusive, non-assignable, non-transferable, non-sub licensable license to use and practice the Technology, solely for the provision of Tissue Processing in the Field of Use and solely within the Territory, and strictly for no other purposes.
License Property
The Licensor has developed patent pending Technology and desires to provide the Technology, certain equipment, ancillary supplies and ancillary services so that Licensee can establish in Licensee’s facility a Tissue Processing laboratory on a turnkey basis for use on domesticated animals' for Licensee's own patients and patients of Veterinarians.
Tissue Processing shall mean the separation of Adipose Stromal Vascular Fraction from fat tissue utilizing the Technology.
Stromal vascular fraction is a regenerative treatment for a number of conditions including osteoarthritis, tendon repair, ligament injuries and other traumatic and degenerative diseases.
Patent Application Ultrasonic Cavitation for the separation of Stromal Vascular Fraction from Adipose Tissue.
Licensee shall use and display the Trademarks only in such forms as specifically approved in writing in advance by the Licensor.
Field of Use
Field of Use means use of the Technology in Tissue Processing used on domesticated animals.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.
